SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonathan Skupsky, Ke-Qin Hu, Current hepatitis B treatment guidelines and future research directions, Frontiers of Medicine, 2014, 8, 2, 145

    CrossRef

  2. 2
    D. T. Chao, J. K. Lim, W. S. Ayoub, L. H. Nguyen, M. H. Nguyen, Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis, Alimentary Pharmacology & Therapeutics, 2014, 39, 4
  3. 3
    Faisal M. Sanai, Mohammed A. Babatin, Khalid I. Bzeizi, Fahad AlSohaibani, Waleed Al–Hamoudi, Khaled O. Alsaad, Hadeel Al Mana, Fayaz A. Handoo, Hamad Al–Ashgar, Hamdan AlGhamdi, Abeer Ibrahim, Abdulrahman Aljumah, Abduljaleel Alalwan, Ibrahim H. AlTraif, Hussa Al–Hussaini, Robert P. Myers, Ayman A. Abdo, Accuracy of International Guidelines for Identifying Significant Fibrosis in Hepatitis B e Antigen–Negative Patients With Chronic Hepatitis, Clinical Gastroenterology and Hepatology, 2013, 11, 11, 1493

    CrossRef

  4. 4
    Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong, Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection, Journal of Clinical Virology, 2013, 58, 4, 641

    CrossRef

  5. 5
    Claudio Puoti, How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?, European Journal of Internal Medicine, 2013, 24, 2, 100

    CrossRef

  6. 6
    Eun-young Cho, Hyung-jin Kim, Channy Park, Hong-seob So, Rae Kil Park, Haak Cheoul Kim, Impact of Nucleotide Mutations at the HNF3- and HNF4-Binding Sites in Enhancer 1 on Viral Replication in Patients with Chronic Hepatitis B Virus Infection, Gut and Liver, 2013, 7, 5, 569

    CrossRef

  7. 7
    Stéphane Chevaliez, Is HBsAg quantification ready, for prime time?, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 6, 559

    CrossRef

  8. 8
    Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, Ivan Fan-Ngai Hung, John Chi-Hang Yuen, Teresa Tong, Ching-Lung Lai, Man-Fung Yuen, Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B, Hepatology International, 2013, 7, 1, 119

    CrossRef

  9. 9
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  10. 10
    C. M. N. Croagh, S. J. Bell, S. Locarnini, P. V. Desmond, Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing, Internal Medicine Journal, 2012, 42, 2
  11. 11
    George V. Papatheodoridis, Spilios Manolakopoulos, Yun-Fan Liaw, Anna Lok, Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review, Journal of Hepatology, 2012, 57, 1, 196

    CrossRef

  12. 12
    Chih-Lin Lin, Tai-Chung Tseng, Tung-Hung Su, Chun-Jen Liu, Pei-Jer Chen, Ming-Yang Lai, Ding-Shinn Chen, Jia-Horng Kao, Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission, Hepatology International, 2012, 6, 3, 598

    CrossRef

  13. 13
    Y.-C. Chen, S.-F. Huang, C.-M. Chu, Y.-F. Liaw, Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion, Journal of Viral Hepatitis, 2012, 19, 2
  14. You have free access to this content14
    Yung-Tsu CHO, Chien-Hung CHEN, Hsien-Yi CHIU, Tsen-Fang TSAI, Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan, The Journal of Dermatology, 2012, 39, 3
  15. 15
    F. M. Sanai, A. Helmy, K. I. Bzeizi, M. A. Babatin, A. Al-Qahtani, H. A. Al-Ashgar, A. S. Al-Mdani, A. Al-Akwaa, S. Almutharea, M. Q. Khan, A. S. Alghamdi, T. Farah, W. Al-Hamoudi, M. Saadeh, A. A. Abdo, Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B, Journal of Viral Hepatitis, 2011, 18, 7
  16. 16
    Chao-Wei Hsu, Chau-Ting Yeh, Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy, Hepatology, 2011, 54, 1
  17. 17
    Chihiro Ishida, Yuichiro Ikebuchi, Kinya Okamoto, Yoshikazu Murawaki, Functional Gene Polymorphisms of Interleukin-10 are Associated with Liver Disease Progression in Japanese Patients with Hepatitis C Virus Infection, Internal Medicine, 2011, 50, 7, 659

    CrossRef

  18. 18
    Tony Andreani, HBV-carriers: When is monitoring and surveillance sufficient? (point of view), Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 813

    CrossRef

  19. 19
    Guoping Peng, Benyan Luo, Jie Li, Dongjiu Zhao, Wei Wu, Feng Chen, Zhi Chen, Hepatitis B e-antigen Persistency is Associated with the Properties of HBV-Specific CD8 T Cells in CHB Patients, Journal of Clinical Immunology, 2011, 31, 2, 195

    CrossRef

  20. 20
    Henry Lik-Yuen Chan, Alex Thompson, Michelle Martinot-Peignoux, Teerha Piratvisuth, Markus Cornberg, Maurizia Rossana Brunetto, Hans L. Tillmann, Jia-Horng Kao, Ji-Dong Jia, Heiner Wedemeyer, Stephen Locarnini, Harry L.A. Janssen, Patrick Marcellin, Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report, Journal of Hepatology, 2011, 55, 5, 1121

    CrossRef

  21. 21
    Dan Bekku, Makoto Arai, Fumio Imazeki, Yutaka Yonemitsu, Tatsuo Kanda, Keiichi Fujiwara, Kenichi Fukai, Kenichi Sato, Sakae Itoga, Fumio Nomura, Osamu Yokosuka, Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2011, 26, 1
  22. 22
    T. Nakazawa, A. Shibuya, A. Takeuchi, Y. Shibata, H. Hidaka, Y. Okuwaki, J. Takada, Y. Tanaka, M. Watanabe, T. Minamino, K. Sakurai, W. Koizumi, Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels, Journal of Viral Hepatitis, 2011, 18, 7
  23. 23
    Yi-Cheng Chen, Chia-Ming Chu, Yun-Fan Liaw, Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B, Hepatology, 2010, 51, 2
  24. 24
    Mamun Al-Mahtab, Salimur Rahman, Sheikh Mohammad Fazle Akbar, Mohammad Kamal, Mohammad Sakirul Islam Khan, Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh, Journal of Medical Virology, 2010, 82, 8
  25. 25
    Andrés Duarte-Rojo, Jordan J. Feld, Hepatitis B Biomarkers: Clinical Significance of the Old and the New, Current Hepatitis Reports, 2010, 9, 4, 187

    CrossRef

  26. 26
    Maurizia Rossana Brunetto, Filippo Oliveri, Piero Colombatto, Francesco Moriconi, Pietro Ciccorossi, Barbara Coco, Veronica Romagnoli, Beatrice Cherubini, Giovanna Moscato, Anna Maria Maina, Daniela Cavallone, Ferruccio Bonino, Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers, Gastroenterology, 2010, 139, 2, 483

    CrossRef

  27. 27
    Chia–Ming Chu, Yi–Cheng Chen, Dar–In Tai, Yun–Fan Liaw, Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase, Clinical Gastroenterology and Hepatology, 2010, 8, 6, 535

    CrossRef

  28. 28
    L.Y. Lin, V.W.S. Wong, H.J. Zhou, H.Y. Chan, H.L. Gui, S.M. Guo, H. Wang, L. Huang, S.S. Bao, Q. Xie, H.L.Y. Chan, Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients, Journal of Medical Virology, 2010, 82, 9
  29. 29
    Dar-In Tai, Pei-Kwei Tsay, Wei-Ting Chen, Chia–Ming Chu, Yun-Fan Liaw, Relative Roles of HBsAg Seroclearance and Mortality in the Decline of HBsAg Prevalence With Increasing Age, The American Journal of Gastroenterology, 2010, 105, 5, 1102

    CrossRef

  30. 30
    Iwona Mozer-Lisewska, Anna Mania, Wojciech Służewski, Paweł Kemnitz, Joanna Prusinowska, Arleta Kowala-Piaskowska, Magdalena Figlerowicz, Factors influencing clinical course and histological findings in children with chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2009, 21, 12, 1400

    CrossRef

  31. 31
    Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu, Hepatitis B e antigen–negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL, Hepatology, 2009, 49, 2
  32. 32
    Yun-Fan Liaw, Chia-Ming Chu, Hepatitis B virus infection, The Lancet, 2009, 373, 9663, 582

    CrossRef

  33. 33
    Chia-Ming Chu, Yun-Fan Liaw, Incidence and Risk Factors of Progression to Cirrhosis in Inactive Carriers of Hepatitis B Virus, The American Journal of Gastroenterology, 2009, 104, 7, 1693

    CrossRef

  34. 34
    Dar-In Tai, Shi-Ming Lin, I-Shyan Sheen, Chia-Ming Chu, Deng-Yn Lin, Yun-Fan Liaw, Long-term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time, Hepatology, 2009, 49, 6
  35. 35
    George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis, Athanasios J. Archimandritis, Reply:, Hepatology, 2009, 49, 2
  36. 36
    Manoj Kumar, Ranjit Chauhan, Nitin Gupta, Syed Hissar, Puja Sakhuja, Shiv K. Sarin, Spontaneous Increases in Alanine Aminotransferase Levels in Asymptomatic Chronic Hepatitis B Virus-Infected Patients, Gastroenterology, 2009, 136, 4, 1272

    CrossRef

  37. 37
    William Alazawi, Graham R Foster, Advances in the diagnosis and treatment of hepatitis B, Current Opinion in Infectious Diseases, 2008, 21, 5, 508

    CrossRef

  38. 38
    Yun-Fan Liaw, Nancy Leung, Jia-Horng Kao, Teerha Piratvisuth, Edward Gane, Kwang-Hyub Han, Richard Guan, George K. K. Lau, Stephen Locarnini, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update, Hepatology International, 2008, 2, 3, 263

    CrossRef

  39. 39
    Jia-Horng Kao, Diagnosis of hepatitis B virus infection through serological and virological markers, Expert Review of Gastroenterology & Hepatology, 2008, 2, 4, 553

    CrossRef

  40. 40
    Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Paul Cheung-Lung Choi, Anthony Wing-Hung Chan, Angel Mei-Ling Chim, Karen Ka-Lam Yiu, Hoi-Yun Chan, Francis Ka-Leung Chan, Joseph Jao-Yao Sung, Henry Lik-Yuen Chan, Evaluation of Alanine Transaminase and Hepatitis B Virus DNA to Predict Liver Cirrhosis in Hepatitis B e Antigen-Negative Chronic Hepatitis B Using Transient Elastography, The American Journal of Gastroenterology, 2008, 103, 12, 3071

    CrossRef

  41. 41
    George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis, John Giannousis, Antonios Bilalis, Georgia Kafiri, Dimitrios Tzourmakliotis, Athanasios J. Archimandritis, Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?, Hepatology, 2008, 48, 5